Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 3
Review
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,379 | Dovepress* | 9,420+ | 1,960 | 11,380 | |
| PubMed Central* | 2,959 | 1,139 | 4,098 | ||
| Totals | 12,379 | 3,099 | 15,478 | ||
| *Since 21 September 2016 | |||||
View citations on PubMed and Google Scholar